TRxADE HEALTH, Inc. (MEDS)
| Previous close | 6.93 |
| Open | 6.81 |
| Bid | 6.45 x 100 |
| Ask | 6.66 x 100 |
| Day's range | 6.47 - 7.25 |
| 52-week range | 3.69 - 44.56 |
| Volume | |
| Avg. volume | 436,377 |
| Market cap | 7.808M |
| Beta (5Y monthly) | 1.93 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -5.46 |
| Earnings date | 22 Apr 2024 - 24 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 25 Mar 2024 |
| 1y target est | N/A |
GlobeNewswireTRxADE Health, Inc. Announces Special Cash Dividend
TAMPA, FL, March 06, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH Inc. (Nasdaq: MEDS) (the “Company”), announced that the Company’s board of directors has declared a special cash dividend of $8.00 per share of common stock. The special dividend is being paid using a portion of the proceeds from the closing of the recently announced sale of the Company’s web-based market platform assets. The special cash dividend is payable to stockholders of record as of March 18, 2024, with the dividend being paid on
- GlobeNewswire
Trxade health, Inc files its 3Q 10Q
TAMPA, FL, Jan. 17, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS) (“TRxADE”), a parent company of pharmaceutical business-to-business exchange platform, announced today that it filed its Quarterly Report on Form 10-Q for the period ended September 30, 2023 (the “Form 10-Q”). On November 21, 2023, the Company received a standard notice of noncompliance from the Nasdaq Listing Qualifications Department (“Nasdaq”) indicating that, as a result of not having timely filed its Form 10-Q,
- GlobeNewswire
TRxADE Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q.
TAMPA, FL, Nov. 29, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS) (“TRxADE”), a parent company of a pharmaceutical business-to-business exchange platform, announced today that it received a notice of non-compliance from the Nasdaq Listing Qualifications Department (“Nasdaq”) on November 21, 2023 notifying the Company that, as a result of the Company’s failure to timely file its Quarterly Report on Form 10-Q for the period ended September 30, 2023 (the “Form 10-Q”), the Company is n
